These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 580534)
41. Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy. Altay C; Seçil M; Demir T; Atik T; Akıncı G; Özdemir Kutbay N; Keskin Temeloğlu E; Yıldırım Şimşir I; Özışık S; Demir L; Eren E; Tuna EB; Aytaç H; Onay H; Akıncı B Diagn Interv Radiol; 2017; 23(6):428-434. PubMed ID: 29044029 [TBL] [Abstract][Full Text] [Related]
42. Observations on fat and carbohydrate metabolism in generalized lipodystrophy. Segall M; Lloyd J Arch Dis Child; 1969 Dec; 44(238):779. PubMed ID: 5356989 [No Abstract] [Full Text] [Related]
43. Congenital lipodystrophy: An endocrine study in three siblings. I. Disorders of carbohydrate metabolism. Huseman C; Johanson A; Varma M; Blizzard RM J Pediatr; 1978 Aug; 93(2):221-6. PubMed ID: 209163 [TBL] [Abstract][Full Text] [Related]
44. Metabolic basis of HIV-lipodystrophy syndrome. Sekhar RV; Jahoor F; White AC; Pownall HJ; Visnegarwala F; Rodriguez-Barradas MC; Sharma M; Reeds PJ; Balasubramanyam A Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E332-7. PubMed ID: 12110539 [TBL] [Abstract][Full Text] [Related]
45. [Congenital generalized lipodystrophy in children]. Letova EK Pediatriia; 1982; (9):64-6. PubMed ID: 7145575 [No Abstract] [Full Text] [Related]
46. Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment. Reyes-Vidal CM; Mojahed H; Shen W; Jin Z; Arias-Mendoza F; Fernandez JC; Gallagher D; Bruce JN; Post KD; Freda PU J Clin Endocrinol Metab; 2015 Aug; 100(8):2946-55. PubMed ID: 26037515 [TBL] [Abstract][Full Text] [Related]
47. Near normalization of metabolic abnormalities by prolonged CSII in a girl with congenital lipodystrophy. Klar A; Corcos AP; Gross-Kieselstein E; Reifen RM; Navon P; Branski D Diabetes Care; 1987; 10(2):257-9. PubMed ID: 3582088 [No Abstract] [Full Text] [Related]
48. [Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue]. Capeau J; Vigouroux C; Magré J; Lascols O; Caron M; Bastard JP C R Biol; 2006 Aug; 329(8):639-52; discussion 653-5. PubMed ID: 16860281 [TBL] [Abstract][Full Text] [Related]
49. A translational view of the genetics of lipodystrophy and ectopic fat deposition. Lanktree MB; Johansen CT; Joy TR; Hegele RA Prog Mol Biol Transl Sci; 2010; 94():159-96. PubMed ID: 21036325 [TBL] [Abstract][Full Text] [Related]
50. Congenital generalized lipodystrophy in a 4-month-old infant. Lee IH; Chen HL; Jeng YM; Cheng MT; Tsao LY; Chang MH J Formos Med Assoc; 2001 Sep; 100(9):623-7. PubMed ID: 11695279 [TBL] [Abstract][Full Text] [Related]
51. [Fat and carbohydrate metabolism in lipodystrophies]. Starkova NT; Lobanova AM; Negovskaia AV; Letova EK Probl Endokrinol (Mosk); 1982; 28(2):12-6. PubMed ID: 7043445 [TBL] [Abstract][Full Text] [Related]
52. Adipose tissue fatty acid storage factors: effects of depot, sex and fat cell size. Hames KC; Koutsari C; Santosa S; Bush NC; Jensen MD Int J Obes (Lond); 2015 Jun; 39(6):884-7. PubMed ID: 25640767 [TBL] [Abstract][Full Text] [Related]
54. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. Simha V; Garg A J Clin Endocrinol Metab; 2003 Nov; 88(11):5433-7. PubMed ID: 14602785 [TBL] [Abstract][Full Text] [Related]
56. Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy. Miehle K; Stumvoll M; Fasshauer M; Hierl T Endocrine; 2017 Nov; 58(2):262-266. PubMed ID: 28993984 [TBL] [Abstract][Full Text] [Related]
57. Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial. van Wijk JP; de Koning EJ; Cabezas MC; op't Roodt J; Joven J; Rabelink TJ; Hoepelman AI Ann Intern Med; 2005 Sep; 143(5):337-46. PubMed ID: 16144892 [TBL] [Abstract][Full Text] [Related]
58. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Vigouroux C; Caron-Debarle M; Le Dour C; Magré J; Capeau J Int J Biochem Cell Biol; 2011 Jun; 43(6):862-76. PubMed ID: 21392585 [TBL] [Abstract][Full Text] [Related]
59. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Agarwal AK; Arioglu E; De Almeida S; Akkoc N; Taylor SI; Bowcock AM; Barnes RI; Garg A Nat Genet; 2002 May; 31(1):21-3. PubMed ID: 11967537 [TBL] [Abstract][Full Text] [Related]
60. Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents. Viganò A; Mora S; Manzoni P; Schneider L; Beretta S; Molinaro M; di Natale B; Brambilla P J Clin Endocrinol Metab; 2005 Jul; 90(7):4075-80. PubMed ID: 15840750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]